Adult blood lead epidemiology and surveillance - United States, Fourth Quarter, 1997.
Lofgren-JP; Schaller-K; Payne-S; Jung-BC; Gergely-R; Davis-W; Keyvan-Larijani-E; Rabin-R; Allemier-A; Falken-M; DeLaurier-C; Gerwel-B; Prophet-R; Stone-R; Randolph-S; Migliozzi-A; Rhoades-E; Sandoval-A; Gostin-J; Stoeckel-M; Gardner-Hillian-A; Salzman-D; Ball-W; Toof-L; Rajaraman-P; Tierney-J; Klietz-T
MMWR 1997 Jul; 47(27):570-573
CDC's National Institute for Occupational Safety and Health Adult Blood Lead Epidemiology and Surveillance program (ABLES) monitors laboratory-reported elevated blood lead levels (BLLs) among adults in the United States. During 1997, a total of 27 states reported surveillance data to ABLES. * This report presents ABLES data through the fourth quarter for 1997 and compares the data for each quarter of 1997 with data reported for the corresponding quarter of 1996; preliminary totals for the fourth quarter 1997 reports suggest that the overall number of persons with BLLs greater than or equal to 25 ug/dL were similar for 1996 and 1997.
Lead-absorption; Lead-compounds; Lead-dust; Blood-analysis; Blood-sampling; Central-nervous-system-disorders; Blood-disorders; Reproductive-system-disorders; Cardiovascular-system-disorders; Kidney-disorders; Environmental-exposure; Exposure-levels; Exposure-limits; Neurotoxic-effects; Surveillance-programs; Region-1; Region-10; Region-2; Region-3; Region-4; Region-5; Region-6; Region-7; Region-8; Region-9
Morbidity and Mortality Weekly Report
AL; CA; AZ; CT; IA; ME; MD; MA; MI; MN; NH; NJ